One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Arthritis Therapeutics Market

Arthritis Therapeutics Market (Type: Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Gout, and Others; Drug Class: TNF Inhibitors, Interleukin Inhibitors, NSAIDs, Corticosteroids, Xanthine Oxidase Inhibitors, and Others; Route of Administration: Oral, Parenteral, and Topical; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027


Product Code : TMRHC00110862
Survey : Transparency Market Research
Publish On : 20, May, 2022
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5795 / Question Form
5 User USD8795 / Question Form
Enterprise User USD11795 / Question Form

Novartis AG
Eli Lilly and Company
Amgen, Inc.
Merck & Co., Inc.
Bristol-Myers Squibb Company
Pfizer, Inc.
AbbVie, Inc.
Janssen Global Services, LLC (Johnson & Johnson)
F. Hoffmann-La Roche Ltd
Sanofi

[Report Description]

Arthritis Therapeutics Market – Scope of the Report

TMR’S report on the global arthritis therapeutics market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global arthritis therapeutics market for the period of 2017–2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global arthritis therapeutics market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global arthritis therapeutics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study the various phenomena in the global arthritis therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global arthritis therapeutics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global arthritis therapeutics market. The next section of the global arthritis therapeutics market report highlights key insights, which include the growing prevalence of rheumatoid arthritis, osteoarthritis, psoriatic arthritis and other types, ongoing clinical trials and pipeline analysis, major arthritis brands in the market, and regulatory scenarios in the global arthritis therapeutics market.

The report delves into the competitive landscape of the global arthritis therapeutics market. Key players operating in the global arthritis therapeutics market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOTs are some of the attributes of players in the global arthritis therapeutics market profiled in this report.

Key Questions Answered in the Arthritis Therapeutics Market Report

How does the recent launching of novel and effective drugs provide scope of growth in the global arthritis therapeutics market?
How are ongoing clinical trials for arthritis widening the scope for arthritis therapeutics?
How are various drug classes effective in the treatment of arthritis, and provide opportunities to key players for growth?
What are the revenue share projections of key segments under various criteria in the global arthritis therapeutics market for the forecast period?
Which segment is likely to lead the arthritis therapeutics market in terms of revenue by 2027?
How are changing regulatory scenarios, along with changing healthcare systems in developed and developing countries having an impact on the overall arthritis therapeutics market?
Arthritis Therapeutics Market – Research Objectives and Research Approach

The comprehensive report on the global arthritis therapeutics market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, and healthcare compliances laid down by accredited agencies in the purview of research in the global arthritis therapeutics market. It is followed by market introduction, market dynamics, and an overview of the global arthritis therapeutics market, which includes TMR analysis of the market drivers, restraints, and trends affecting the growth of the global arthritis therapeutics market. Furthermore, to understand the Y-o-Y trends of the arthritis therapeutics market, a Y-o-Y analysis with elaborated insights on the same have been provided. The next section of the global arthritis therapeutics report highlights key insights, which include growing prevalence of arthritis disease across the globe, top analysis of key brands, pipeline analysis, and key industry developments in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of the actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. To ascertain the size of the global arthritis therapeutics market in terms of value, revenue generated by key arthritis drugs manufacturers has been mapped. The forecast presented here assesses the total revenue generated in the arthritis therapeutics market.

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Arthritis Therapeutics Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Arthritis Therapeutics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Key product/brand Analysis

5.2. Pipeline Analysis

5.3. Disease Prevalence & Incidence Rate globally with key countries

5.4. Regulatory Scenario by Region/globally

6. Global Arthritis Therapeutics Market Analysis and Forecast, By Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

6.3.1. Rheumatoid Arthritis

6.3.2. Osteoarthritis

6.3.3. Psoriatic Arthritis

6.3.4. Gout

6.3.5. Others

6.4. Market Attractiveness By Type

7. Global Arthritis Therapeutics Market Analysis and Forecast, By Drug Class

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

7.3.1. TNF Inhibitors

7.3.2. Interleukin Inhibitors

7.3.3. NSAIDs

7.3.4. Corticosteroids

7.3.5. Xanthine Oxidase Inhibitors

7.3.6. Others

7.4. Market Attractiveness By Drug Class

8. Global Arthritis Therapeutics Market Analysis and Forecast, By Route of Administration

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

8.3.1. Oral

8.3.2. Parenteral

8.3.3. Topical

8.4. Market Attractiveness By Route of Administration

9. Global Arthritis Therapeutics Market Analysis and Forecast, By Distribution Channel

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. Market Attractiveness By Distribution Channel

10. Global Arthritis Therapeutics Market Analysis and Forecast, By Region

10.1. Key Findings

10.2. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness By Country/Sub-region /Region

11. North America Arthritis Therapeutics Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

11.2.1. Rheumatoid Arthritis

11.2.2. Osteoarthritis

11.2.3. Psoriatic Arthritis

11.2.4. Gout

11.2.5. Others

11.3. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

11.3.1. TNF Inhibitors

11.3.2. Interleukin Inhibitors

11.3.3. NSAIDs

11.3.4. Corticosteroids

11.3.5. Xanthine Oxidase Inhibitors

11.3.6. Others

11.4. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

11.4.1. Oral

11.4.2. Parenteral

11.4.3. Topical

11.5. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online Pharmacies

11.6. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. North America Market Attractiveness Analysis

11.7.1. By Type

11.7.2. By Drug Class

11.7.3. By Route of Administration

11.7.4. By Distribution Channel

11.7.5. By Country/Sub-region

12. Europe Arthritis Therapeutics Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

12.2.1. Rheumatoid Arthritis

12.2.2. Osteoarthritis

12.2.3. Psoriatic Arthritis

12.2.4. Gout

12.2.5. Others

12.3. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

12.3.1. TNF Inhibitors

12.3.2. Interleukin Inhibitors

12.3.3. NSAIDs

12.3.4. Corticosteroids

12.3.5. Xanthine Oxidase Inhibitors

12.3.6. Others

12.4. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

12.4.1. Oral

12.4.2. Parenteral

12.4.3. Topical

12.5. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

12.5.1. Hospital Pharmacies

12.5.2. Retail Pharmacies

12.5.3. Online Pharmacies

12.6. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe Market Attractiveness Analysis

12.7.1. By Type

12.7.2. By Drug Class

12.7.3. By Route of Administration

12.7.4. By Distribution Channel

12.7.5. By Country/Sub-region

13. Asia Pacific Arthritis Therapeutics Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

13.2.1. Rheumatoid Arthritis

13.2.2. Osteoarthritis

13.2.3. Psoriatic Arthritis

13.2.4. Gout

13.2.5. Others

13.3. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

13.3.1. TNF Inhibitors

13.3.2. Interleukin Inhibitors

13.3.3. NSAIDs

13.3.4. Corticosteroids

13.3.5. Xanthine Oxidase Inhibitors

13.3.6. Others

13.4. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

13.4.1. Oral

13.4.2. Parenteral

13.4.3. Topical

13.5. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

13.5.1. Hospital Pharmacies

13.5.2. Retail Pharmacies

13.5.3. Online Pharmacies

13.6. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017–2027

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific Market Attractiveness Analysis

13.7.1. By Type

13.7.2. By Drug Class

13.7.3. By Route of Administration

13.7.4. By Distribution Channel

13.7.5. By Country/Sub-region

14. Latin America Arthritis Therapeutics Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

14.2.1. Rheumatoid Arthritis

14.2.2. Osteoarthritis

14.2.3. Psoriatic Arthritis

14.2.4. Gout

14.2.5. Others

14.3. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

14.3.1. TNF Inhibitors

14.3.2. Interleukin Inhibitors

14.3.3. NSAIDs

14.3.4. Corticosteroids

14.3.5. Xanthine Oxidase Inhibitors

14.3.6. Others

14.4. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

14.4.1. Oral

14.4.2. Parenteral

14.4.3. Topical

14.5. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

14.5.1. Hospital Pharmacies

14.5.2. Retail Pharmacies

14.5.3. Online Pharmacies

14.6. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America Market Attractiveness Analysis

14.7.1. By Type

14.7.2. By Drug Class

14.7.3. By Route of Administration

14.7.4. By Distribution Channel

14.7.5. By Country/Sub-region

15. Middle East & Africa Arthritis Therapeutics Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

15.2.1. Rheumatoid Arthritis

15.2.2. Osteoarthritis

15.2.3. Psoriatic Arthritis

15.2.4. Gout

15.2.5. Others

15.3. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

15.3.1. TNF Inhibitors

15.3.2. Interleukin Inhibitors

15.3.3. NSAIDs

15.3.4. Corticosteroids

15.3.5. Xanthine Oxidase Inhibitors

15.3.6. Others

15.4. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

15.4.1. Oral

15.4.2. Parenteral

15.4.3. Topical

15.5. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

15.5.1. Hospital Pharmacies

15.5.2. Retail Pharmacies

15.5.3. Online Pharmacies

15.6. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Middle East & Africa Market Attractiveness Analysis

15.7.1. By Type

15.7.2. By Drug Class

15.7.3. By Route of Administration

15.7.4. By Distribution Channel

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Share Analysis By Company (2018)

16.2. Company Profiles

16.2.1. Novartis AG

16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.1.2. Financial Overview

16.2.1.3. Product Portfolio

16.2.1.4. Strategic Overview

16.2.1.5. SWOT Analysis

16.2.2. Eli Lilly and Company

16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.2.2. Financial Overview

16.2.2.3. Product Portfolio

16.2.2.4. Strategic Overview

16.2.2.5. SWOT Analysis

16.2.3. Amgen, Inc.

16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.3.2. Financial Overview

16.2.3.3. Product Portfolio

16.2.3.4. Strategic Overview

16.2.3.5. SWOT Analysis

16.2.4. Merck & Co., Inc.

16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.4.2. Financial Overview

16.2.4.3. Product Portfolio

16.2.4.4. Strategic Overview

16.2.4.5. SWOT Analysis

16.2.5. Bristol-Myers Squibb Company

16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.5.2. Financial Overview

16.2.5.3. Product Portfolio

16.2.5.4. Strategic Overview

16.2.5.5. SWOT Analysis

16.2.6. Pfizer, Inc.

16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.6.2. Financial Overview

16.2.6.3. Product Portfolio

16.2.6.4. Strategic Overview

16.2.6.5. SWOT Analysis

16.2.7. AbbVie, Inc.

16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.7.2. Financial Overview

16.2.7.3. Product Portfolio

16.2.7.4. Strategic Overview

16.2.7.5. SWOT Analysis

16.2.8. Janssen Global Services, LLC (Johnson & Johnson)

16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.8.2. Financial Overview

16.2.8.3. Product Portfolio

16.2.8.4. Strategic Overview

16.2.8.5. SWOT Analysis

16.2.9. F. Hoffmann-La Roche Ltd

16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.9.2. Financial Overview

16.2.9.3. Product Portfolio

16.2.9.4. Strategic Overview

16.2.9.5. SWOT Analysis

16.2.10. Sanofi

16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.10.2. Financial Overview

16.2.10.3. Product Portfolio

16.2.10.4. Strategic Overview

16.2.10.5. SWOT Analysis

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+